FDA Import Refusal AEK-4867451-7/11/1 — BOEHRINGER INGELHEIM INDIA PRIVA
The FDA refused shipment AEK-4867451-7/11/1 from BOEHRINGER INGELHEIM INDIA PRIVA (India) on Mar 19, 2024. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75
Refusal details
- Date
- Mar 19, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75